concern over the storage of Pfizer vaccine

The announcement by American pharmaceutical major Pfizer about Covid-19 vaccine trial has led to renewed hopes in a wold battered by the coronavirus pandemic. Experts, however, point towards the logistics of giving the potential vaccine to a larger population.

One of those experts is director of the premier All India Institute of Medical Sciences (AIIMS) Randeep Guleria. He has expressed concern over the storage of Pfizer vaccine highlighting that the shots need to be kept at minus 70 degrees Celsius which would be a challenge for developing countries like India.